BioCryst Pharmaceuticals/ US09058V1035 /
18/06/2024 21:59:53 | Chg. -0.25 | Volume | Bid- | Demandez à- | Haut | Bas |
---|---|---|---|---|---|---|
6.00USD | -4.00% | 49,813 Chiffrre d'affaires: 300,623.32 |
-Bid taille: - | -Ask la taille: - | 6.12 | 6.00 |
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...
GlobeNewswire
10:00
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Co...
GlobeNewswire
09:05
Artificial Superintelligence Alliance Super Launch Summit Ushers in New Era of Decentralized ASI
Newsfile Corp
09:01
ReGen III Invited to Prepare Part II Application for U.S. Department of Energy Loan Guarantee
GlobeNewswire
09:00
Waterfall Becomes First Proof-of-Stake Network to Pass the Test with 1.5 Million Validators
GlobeNewswire
08:17
Verisk Estimates Industry Insured Losses from Flooding in Southern Germany to Range from EUR 2.4 Bil...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page